Explain this page
Arphra AIPlain-English read on Bio-Techne Corporation’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
- RVMDRevolution Medicines, Inc.$139.48$29.65B
- MRNAModerna, Inc.$45.37$17.99B
- JAZZJazz Pharmaceuticals plc$202.72$12.72B
- MDGLMadrigal Pharmaceuticals, Inc.$513.72$11.78B
- EXELExelixis, Inc.$43.68$11.1B
- BMRNBioMarin Pharmaceutical Inc.$54.06$10.4B
- QGENQiagen N.V.$34.25$7.06B
- CORTCorcept Therapeutics Incorporated$51.42$5.52B
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.15% | +6.31% | -5.93% | -12.27% | -18.82% | -11.99% | +6.48% | -36.64% | -49.53% | +85.92% | +47221.27% |
Aftermarket
LiveLast trade
$51.76
6 sh
Bid
$51.74
100 sh
Ask
$51.80
26 sh
Spread
$0.060
Sector & industry today
LiveSectors
- Technology+4.11%
- Basic Materials+1.08%
- Energy+0.87%
- Industrials+0.37%
- Consumer Cyclical+0.34%
- Communication Services+0.08%
- Utilities-0.27%
- Real Estate-0.63%
- Consumer Defensive-0.82%
- Financial Services-1.11%
- Healthcare-1.21%
Top industries (issuer's industry highlighted)
- Biotechnology-2.51%
- Computer Hardware+7.50%
- Software - Infrastructure+7.00%
- Coal+4.70%
- Semiconductors+4.59%
- Luxury Goods-4.44%
- Consulting Services+4.19%
- Staffing & Employment Services+4.08%
- Broadcasting+3.74%
- Copper+3.51%
- Medical - Equipment & Services+3.50%
- Electronic Gaming & Multimedia-3.39%
Fair value
Football field →Weighted blend
$27.83
-46.23% vs spot
Recommendation
Sell
18 of 19 methods
Method spread
1bull17bear
±5% threshold
Analyst PT consensus: $69.33 (+33.95%)
Total assets
$2.56B
Total debt
$444.06M
Cash & equiv
$162.19M
Operating CF
$287.56M
Free cash flow
$256.55M
Buybacks
-$275.73M
Analyst view
DB · price_targets + analyst_gradesConsensus target
$69.33
+33.95% upside
Low
$62.00
Median
$69.00
High
$79.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- CMB.TECH announces Q1 2026 results on 19/05/2026globenewswire.com·May 07, 2026
- Bio-Techne Releases Third Quarter Fiscal 2026 Resultsprnewswire.com·May 06, 2026
- Bio-Techne Declares Dividendprnewswire.com·May 06, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 Dec 2025 | $295.88M | $38.01M | $0.24 |
| Q1 Sep 2025 | $286.56M | $38.19M | $0.24 |
| Q4 Jun 2025 | $316.96M | -$17.68M | $-0.11 |
| Q3 Mar 2025 | $316.18M | $22.59M | $0.14 |
| Q2 Dec 2024 | $297.03M | $34.89M | $0.22 |
| Q1 Sep 2024 | $289.46M | $33.6M | $0.21 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Herr Amy E. director | Sell | 1,976 | $116.79K | Feb 17, 2026 |
Nusse Roeland director | Sell | 17,040 | $960.39K | Aug 25, 2025 |
BAUMGARTNER ROBERT V director | Sell | 17,040 | $957.82K | Aug 25, 2025 |
Herr Amy E. director | Sell | 1,280 | $63.7K | Jun 09, 2025 |
Herr Amy E. director | Sell | 1,860 | $122.69K | Feb 14, 2025 |
Kelderman Kim director, officer: Chief Executive Officer | Sell | 11,731 | $905.53K | Jan 27, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $1.22B | $102.26M | $73.4M | $0.46 | +6.02% |
| FY 2024 | $1.16B | $206.69M | $168.11M | $1.05 | +14.50% |
| FY 2023 | $1.14B | $298.94M | $285.26M | $1.76 | +25.10% |
| FY 2022 | $1.11B | $296.59M | $272.05M | $1.66 | +24.61% |
| FY 2021 | $931.03M | $237.3M | $140.41M | $0.87 | +15.08% |